Altamira Therapeutics Statistics
Total Valuation
CYTOF has a market cap or net worth of 293,204. The enterprise value is 1.08 million.
Market Cap | 293,204 |
Enterprise Value | 1.08M |
Important Dates
The next estimated earnings date is Thursday, September 18, 2025.
Earnings Date | Sep 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CYTOF has 5.72 million shares outstanding. The number of shares has increased by 2,059.74% in one year.
Current Share Class | 5.72M |
Shares Outstanding | 5.72M |
Shares Change (YoY) | +2,059.74% |
Shares Change (QoQ) | +74.89% |
Owned by Insiders (%) | 19.66% |
Owned by Institutions (%) | 0.00% |
Float | 4.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.07 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.19 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.25 |
Financial Position
The company has a current ratio of 0.11, with a Debt / Equity ratio of 0.19.
Current Ratio | 0.11 |
Quick Ratio | 0.09 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | -0.18 |
Interest Coverage | -109.87 |
Financial Efficiency
Return on equity (ROE) is -108.79% and return on invested capital (ROIC) is -59.89%.
Return on Equity (ROE) | -108.79% |
Return on Assets (ROA) | -45.75% |
Return on Invested Capital (ROIC) | -59.89% |
Return on Capital Employed (ROCE) | -115.39% |
Revenue Per Employee | n/a |
Profits Per Employee | -513,903 |
Employee Count | 11 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 2.75 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.08 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 41.17 |
Average Volume (20 Days) | 7,996 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.92 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.56M |
Pretax Income | -5.65M |
Net Income | -5.65M |
EBITDA | n/a |
EBIT | -5.56M |
Earnings Per Share (EPS) | -1.31 |
Balance Sheet
The company has 3,755 in cash and 790,049 in debt, giving a net cash position of -786,294 or -0.14 per share.
Cash & Cash Equivalents | 3,755 |
Total Debt | 790,049 |
Net Cash | -786,294 |
Net Cash Per Share | -0.14 |
Equity (Book Value) | 4.07M |
Book Value Per Share | 0.71 |
Working Capital | -2.06M |
Cash Flow
In the last 12 months, operating cash flow was -4.29 million and capital expenditures -103,087, giving a free cash flow of -4.40 million.
Operating Cash Flow | -4.29M |
Capital Expenditures | -103,087 |
Free Cash Flow | -4.40M |
FCF Per Share | -0.77 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CYTOF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2,059.74% |
Shareholder Yield | n/a |
Earnings Yield | -1,927.98% |
FCF Yield | -1,499.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2023. It was a reverse split with a ratio of 0.05.
Last Split Date | Dec 13, 2023 |
Split Type | Reverse |
Split Ratio | 0.05 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |